社区获得性肺炎两种治疗方案的成本-效果分析

目的评价两种治疗方案对治疗社区获得性肺炎的药物经济学效果,指导合理用药。方法对两种治疗方案运用成本-效果分析法进行分析。结果两种治疗方案中,单用莫西沙星（A组）总成本为4 092.75元,联合使用阿奇霉素和头孢呋辛（B组）总成本为3 306.83元;有效率分别为88.89%和85.71%;单位效果的增量成本分别为46.04元和38.58元。结论联合使用阿奇霉素和头孢呋辛治疗社区获得性肺炎更为经济合理。

Cost-effectiveness analysis of community-acquired pneumonia therapeutic treatments

Objective To evaluate the pharmacoeconomics effectiveness of two community-acquired pneumonia therapeutic treatments,and provide guidance for rational drug use.Methods Two therapeutic schemes were analyzed through cost-effectiveness analysis.Result Between the two treatments,the total cost by using moxifloxacin alone（Group A） was 4 092.75 RMB,while that of using azithromycin and cefuroxime（Group B） combined was 3 306.83 RMB; the effective rates were 88.89% and 85.71%,respectively; the incremental cost for each effect unit of these two treatments was 46.04 RMB and 38.58 RMB.Conclusion It is more economical and reasonable to use azithromycin and cefuroxime combination for the therapeutic treatment of community-acquired pneumonia.